ArticleNeuropsychiatric disease and treatment2017

Exploring the long-term safety of asenapine in adults with schizophrenia in a double-blind, fixed-dose, extension study.

Suresh Durgam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.